NDRG2 and metastatic malignant neoplasm in the lymph nodes: It was proposed that, in clinical investigations, NDRG2 is positively correlated with survival rate and disease-free survival (DFS) probability, and negatively correlated with lymph node metastasis and TNM stage [4,5,6].